Petauri™ Further Expands Global Pricing and Market Access Capabilities With Key Leadership Hires
Rapidly growing pharmaceutical services platform announces the addition of accomplished executives to the organization’s global pricing and market access team.
NASHVILLE, Tenn (June 18, 2025) — Petauri, a leading purpose-built pharmaceutical services platform, announced today the addition of accomplished consultants Catherine Beecher and Sam Davies as Directors in Petauri Evidence, further strengthening the organization’s Global Pricing and Market Access (GPMA) team.
“It’s an exciting time for the business as we enhance our already exceptional team with proven leaders who bring deep pricing and market access knowledge, and real-world expertise in navigating the complex global landscape,” said David Niziol, President of Petauri Evidence. “Sam and Catherine join our expert team of pricing and market access consultants, led by Clare Foy and Adam Brown. The team collaborates with leading Pharmaceutical and Medical Device companies to develop pricing and market access strategies underpinned by evidence and payer insight, ensuring our clients are set up for success across global markets. This strategic growth, with the addition of Catherine and Sam, means we can deliver even greater expertise and experience—from early market landscaping through pricing and market access strategy, value proposition development, and launch readiness.”
Catherine Beecher joins Petauri with more than 25 years of global pricing and market access experience, having led strategic pricing, reimbursement, and access engagements across a broad portfolio of therapeutic areas. She brings a track record of working as a true partner with her clients to shape successful global pricing, market access, and evidence generation strategies—from early development through launch and lifecycle management.
Sam Davies joins Petauri with a substantial background in pricing, reimbursement, and access having led the Northern European hub for a leading pharmaceutical company supporting several therapeutic areas. In this role, Sam focused on leading the development of practical, evidence-based strategies to support market access across both public and private healthcare channels. His work has included shaping pricing approaches, supporting reimbursement submissions, and collaborating with regional and local stakeholders across therapeutic areas such as cardiometabolic health, immunology, and neuroscience.
This expansion of Petauri’s global strategic consulting services complements the organization’s US pricing and market access capabilities and further signifies their commitment to providing tailored support and innovative solutions that optimize value, drive access, and ultimately improve patient outcomes worldwide.
Learn more at https://petauri.com/gpma/
About Petauri
Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill Capital, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in global market access, medical affairs, commercialization support, patient services, and data and analytics.
Since it was founded in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group, the agencies of FORCE Communications, Mtech Access, Delta Hat, the agencies of the Brightly Network, and Formulary Insights, all now Powered by Petauri™. The legacy organizations now comprise Petauri’s 5 business units—Petauri Advance, Petauri Advisors, Petauri Evidence, Petauri Kinect, and Petauri MAx. Over time, Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances.
From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care. For more information, please visit www.petauri.com.
Media Contact:
Liz Gulino
Petauri
Liz.Gulino@petauri.com
973-476-1751